Jubilant Pharmova : Sustainability Report 2022-23 -December 27, 2023 at 05:50 am EST
Forward and Onward for SustainABLE Lives ...
Source: marketscreener.com
Stay updated with breaking news from Draximage Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Forward and Onward for SustainABLE Lives ...
For this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy designation from the US FDA.